Atlas Trials

Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks

Clinical trial NCT02179775 · UNKNOWN

Trial details

NCT number
NCT02179775
Sponsor
Shiraz University of Medical Sciences
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Migraine HeadacheGastric Diseases
Start date
2014-07-01
Primary completion
2014-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.